Centers for Disease Control and Prevention, Division of HIV/AIDS Prevention, Atlanta, Georgia.
Cerner Corp, Kansas City, Missouri.
AIDS. 2018 Sep 10;32(14):2033-2042. doi: 10.1097/QAD.0000000000001921.
Sexual HIV transmission is more likely to occur when plasma HIV RNA level (viral load) exceeds 1500 copies/ml. We assessed the percentage of person-time spent with viral load above 1500 copies/ml (pPT >1500) among adults with HIV in care.
Observational cohort in eight United States HIV clinics.
Participants had at least one HIV Outpatient Study (HOPS) clinic visit and at least two viral loads during 2000-2014. We assessed pPT above 1500 in time intervals between consecutive viral load pairs, overall and by ART status. Trends in pPT above 1500 and associations between pPT above 1500 and chosen baseline demographics and clinical characteristics were analyzed using generalized estimating equations.
There were 5873 patients contributing 37 794 person-years; 86.0% person-years had prescribed ART, with increasing coverage over time. Over 2000-2014 pPT above 1500 was 24.2%, decreasing from 38.3% in 2000-2002 to 11.3% in 2012-2014. During observation time with ART prescribed, pPT above 1500 was 16.4% overall, decreasing from 29.9% in 2000-2002 to 8.0% in 2012-2014. pPT above 1500 was higher in patients less than 35 vs. at least 50 years old (31.5 vs. 15.6%), women vs. men (30.8 vs. 22.3%), and black vs. white and Latino/Hispanic patients (32.7 vs. 19.9 and 23.7%, respectively). Multivariable correlates of higher pPT above 1500 included no prescribed ART, being younger, non-Hispanic black vs. white, baseline viral load above 1500 copies/ml or lower CD4 count, and baseline public vs. private insurance.
pPT above 1500 declined during 2000-2014. Results support decreasing HIV transmission risk from persons in HIV care over the last decade, and the need to focus interventions on patient groups more consistently viremic.
当血浆 HIV RNA 水平(病毒载量)超过 1500 拷贝/ml 时,性传播 HIV 的可能性更大。我们评估了接受治疗的 HIV 感染者中有多少人处于病毒载量超过 1500 拷贝/ml 的时间百分比(pPT>1500)。
在美国八家 HIV 诊所进行的观察性队列研究。
参与者至少有一次 HIV 门诊研究(HOPS)就诊,并且在 2000-2014 年期间至少有两次病毒载量检测。我们评估了连续两次病毒载量检测之间时间间隔内 pPT>1500 的情况,总体评估以及根据抗逆转录病毒治疗(ART)状况评估。使用广义估计方程分析 pPT>1500 的趋势以及 pPT>1500 与选定的基线人口统计学和临床特征之间的关系。
共有 5873 名患者,共贡献了 37794 人年;86.0%的人年接受了 ART 治疗,且随着时间的推移,覆盖率不断增加。2000-2014 年期间,pPT>1500 的比例为 24.2%,呈下降趋势,从 2000-2002 年的 38.3%降至 2012-2014 年的 11.3%。在接受处方 ART 的观察时间内,总体上 pPT>1500 的比例为 16.4%,从 2000-2002 年的 29.9%降至 2012-2014 年的 8.0%。年龄小于 35 岁与至少 50 岁(31.5%比 15.6%)、女性与男性(30.8%比 22.3%)、非裔美国人与白人和拉丁裔/西班牙裔患者(32.7%比 19.9%和 23.7%)相比,pPT>1500 的比例更高。更高的 pPT>1500 的多变量相关因素包括未接受 ART 治疗、年龄较小、非裔美国人与白人、基线病毒载量>1500 拷贝/ml 或较低的 CD4 计数以及基线公共保险与私人保险。
2000-2014 年期间,pPT>1500 呈下降趋势。结果支持在过去十年中 HIV 感染者的 HIV 传播风险不断降低,需要将干预措施重点放在病毒血症更一致的患者群体上。